Table 2.
The correlations between NAT10, MN, cGAS, STING, IRF3, HIF1A and clinical features.
| NAT10 | MN | cGAS | STING | IRF3 | HIF1A | |
|---|---|---|---|---|---|---|
| Histological grading | 0.038* | 0.889 | 0.457 | 0.209 | 0.201 | 0.293 |
| PDC | 0.003 | 0.001+ | 0.985 | 0.287 | 0.318 | 0.221 |
| Invasion depth | 0.156 | 0.083 | 0.486 | 0.227 | 0.103 | 0.616 |
| Lymph node metastasis | 0.343 | < 0.001* | 0.942 | 0.832 | 0.152 | 0.814 |
| Distant metastasis | 0.046* | 0.559 | 0.240 | 0.834 | 0.043* | 0.933 |
| TNM stage | 0.260 | 0.049* | 0.671 | 0.928 | 0.102 | 0.811 |
| Duke stage | 0.326 | 0.083 | 0.560 | 0.857 | 0.183 | 0.962 |
Note: *P < .05; For correlations between tumor marker and PDC stage, significance was taken as +P ≤ .001